Literature DB >> 8735095

Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA.

B Weber1, W Melchior, W Preiser, G Hess, M Wahl, J Braner, H W Doerr.   

Abstract

A new modular automated enzyme immunoassay (EIA) (Enzymun-Test HIV Ag: Boehringer Mannheim) for quantitative human immunodeficiency virus (HIV) antigen detection was evaluated by testing a panel of 1,506 serum samples, including seroconversions, dilution series, follow-up samples from patients under antiretroviral therapy, single serum specimens from HIV-seropositive individuals in different stages of infection, potentially cross-reactive samples, and sera from HIV-negative hospitalized patients. The Abbott HIV type 1 (HIV-1) antigen monoclonal antibody assay served as the reference assay, and nucleic acid sequence-based amplification (Organon Teknika) for quantitative amplification of HIV-1 RNA was used for follow-up of patients under antiretroviral chemotherapy. The Boehringer Mannheim and Abbott EIAs showed concordant results for the early detection of HIV antigen in all the seroconversion panels. The follow-up samples from 29 HIV-infected individuals under antiretroviral therapy gave divergent results between both antigen tests. For the detection of HIV antigen in single serum samples from HIV-infected patients in different stages of HIV infection, a higher number of positive samples was detected with the Abbott HIV-1 antigen monoclonal antibody assay in samples from patients in stages II and III of HIV infection. The Enzymun-Test detected three or more positive samples than did the Abbott assay among the samples of patients with AIDS. The concordance on a sample-to-sample basis between the Boehringer Mannheim and Abbott EIAs was 98.6%. The sensitivity of the Enzymun-Test in comparison to the reference assay was 97.2%; the specificity was 98.8%. Although no close correlation could be found between the amount of viral RNA in serum detected by nucleic acid sequence-based amplification and the concentration of HIV antigen, a high HIV-1 RNA copy number was mostly associated with high levels of HIV antigen. In conclusion, the Enzymun-Test permits accurate HIV antigen detection and offers, in contrast to previous assays, the possibility of completely automated detection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735095      PMCID: PMC229039          DOI: 10.1128/jcm.34.6.1440-1447.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.

Authors:  I Van Kerckhoven; G Vercauteren; P Piot; G van der Groen
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 2.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

3.  Viral burden in AIDS.

Authors:  R F Garry; C D Fermin
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

4.  Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag.

Authors:  M Tersmette; I N Winkel; M Groenink; R A Gruters; R P Spence; E Saman; G Van Der Groen; F Miedema; J G Huisman
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

5.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

Authors:  D R Henrard; S Wu; J Phillips; D Wiesner; J Phair
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH.

Authors:  R A Pokriefka; O Manzor; N P Markowitz; L D Saravolatz; P Kvale; R M Donovan
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.

Authors:  S A Spector; C Kennedy; J A McCutchan; S A Bozzette; R G Straube; J D Connor; D D Richman
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

9.  HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.

Authors:  I Loussert-Ajaka; T D Ly; M L Chaix; D Ingrand; S Saragosti; A M Couroucé; F Brun-Vézinet; F Simon
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

10.  Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques.

Authors:  W Borkowsky; K Krasinski; H Pollack; W Hoover; A Kaul; T Ilmet-Moore
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.